Senseonics (NYSE:SENS) Receives New Coverage from Analysts at StockNews.com (2024)

StockNews.com began coverage on shares of Senseonics (NYSE:SENS - Free Report) in a report released on Thursday morning. The firm issued a sell rating on the stock.

Senseonics Stock Up 5.0 %

Shares of Senseonics stock traded up $0.02 during midday trading on Thursday, reaching $0.47. 4,939,342 shares of the company's stock traded hands, compared to its average volume of 2,271,769. Senseonics has a 52 week low of $0.37 and a 52 week high of $1.05. The company has a debt-to-equity ratio of 1.79, a quick ratio of 3.70 and a current ratio of 3.96. The company's 50 day simple moving average is $0.43 and its 200 day simple moving average is $0.51. The company has a market cap of $249.04 million, a price-to-earnings ratio of -3.35 and a beta of 0.82.

Senseonics (NYSE:SENS - Get Free Report) last posted its quarterly earnings data on Monday, May 13th. The company reported ($0.03) EPS for the quarter, hitting analysts' consensus estimates of ($0.03). Senseonics had a negative return on equity of 202.32% and a negative net margin of 346.38%. The business had revenue of $5.05 million for the quarter, compared to analyst estimates of $4.76 million. Equities analysts expect that Senseonics will post -0.12 earnings per share for the current fiscal year.

Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now.But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Hedge Funds Weigh In On Senseonics

Several institutional investors and hedge funds have recently modified their holdings of the stock. RPO LLC bought a new stake in shares of Senseonics during the 4th quarter valued at approximately $37,000. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Senseonics by 30.2% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company's stock worth $483,000 after buying an additional 211,128 shares during the period. State Board of Administration of Florida Retirement System bought a new position in Senseonics during the first quarter worth $91,000. Vanguard Group Inc. boosted its position in Senseonics by 0.7% during the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company's stock valued at $11,963,000 after acquiring an additional 155,715 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in Senseonics by 16.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company's stock worth $196,000 after acquiring an additional 51,000 shares during the period. 12.36% of the stock is currently owned by institutional investors and hedge funds.

Senseonics Company Profile

(Get Free Report)

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.

Recommended Stories

  • Five stocks we like better than Senseonics
  • Using the MarketBeat Stock Split Calculator
  • Sales Breakout Sends This Semiconductor Stock to Record High
  • 3 Tickers Leading a Meme Stock Revival
  • Surprise Buying Opportunity on This Dividend Aristocrat
  • Quiet Period Expirations Explained
  • New Theme Park Powerhouse: Merger Creates Industry-Leading Stock

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)Senseonics (NYSE:SENS) Receives New Coverage from Analysts at StockNews.com (3)

Should you invest $1,000 in Senseonics right now?

Before you consider Senseonics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Senseonics wasn't on the list.

While Senseonics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Senseonics (NYSE:SENS) Receives New Coverage from Analysts at StockNews.com (4)

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Senseonics (NYSE:SENS) Receives New Coverage from Analysts at StockNews.com (2024)

FAQs

Does SENS stock have a future? ›

SENS Stock 12 Month Forecast

Based on 2 Wall Street analysts offering 12 month price targets for Senseonics Holdings in the last 3 months. The average price target is $2.50 with a high forecast of $2.50 and a low forecast of $2.50. The average price target represents a 426.32% change from the last price of $0.48.

What is the target price for Senseonics stock? ›

Analyst Price Targets

Based on analysts offering 12 month price targets for SENS in the last 3 months. The average price target is $2.5 with a high estimate of $2.5 and a low estimate of $2.5.

What is happening with Senseonics? ›

Senseonics expects full year 2024 global net revenue to be in the range of $22 million to $24 million . The full year 2024 financial outlook assumes more than doubling the U.S. new patient starts and increasing the global installed base by approximately 50% in 2024 compared to 2023.

How many shares does SENS have? ›

Senseonics Holdings Inc has 530,886,400 shares outstanding.

What is Senseonics stock prediction for 2025? ›

According to analysts, SENS price target is 1.40 USD with a max estimate of 2.50 USD and a min estimate of 0.30 USD.

What is the stock forecast for Senseonics in 2024? ›

According to our current SENS stock forecast, the value of Senseonics Holdings shares will rise by 6.49% and reach $ 0.417644 per share by July 12, 2024. Per our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).

Who owns Senseonics stock? ›

Largest shareholders include Vanguard Group Inc, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, BlackRock Inc., VEXMX - Vanguard Extended Market Index Fund Investor Shares, Masters Capital Management Llc, Geode Capital Management, Llc, IHI - iShares U.S. Medical Devices ETF, Charles Schwab Investment ...

What is Senseonics net worth? ›

Senseonics Holdings has a market cap or net worth of $201.74 million as of June 21, 2024. Its market cap has decreased by -44.61% in one year.

What is the target price prediction? ›

TGT Stock 12 Month Forecast

Based on 28 Wall Street analysts offering 12 month price targets for Target in the last 3 months. The average price target is $176.76 with a high forecast of $209.00 and a low forecast of $116.00. The average price target represents a 15.64% change from the last price of $152.85.

What is the fair value of SENS stock? ›

As of 2024-07-08, the Fair Value of Senseonics Holdings Inc (SENS) is -0.76 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.39 USD, the upside of Senseonics Holdings Inc is -293.5%.

Who are Senseonics competitors? ›

Competitor comparison
  • Abbott Laboratories Headquarters. 114,000. $40.1B.
  • DexCom Inc Headquarters. 9,600. $3.6B.
  • Tandem Diabetes Care Inc Headquarters. 2,400. $747.7M.
  • ACON Laboratories Inc Headquarters.

Will SENS get FDA approval? ›

[Image from Ascensia/Senseonics] The FDA today granted integrated CGM (iCGM) designation to the Eversense continuous glucose monitoring system from Senseonics (NYSE:SENS).

What is Senseonics stock target? ›

Stock Price Targets
High$2.50
Median$1.40
Low$0.30
Average$1.40
Current Price$0.47

What is the P E ratio of Sens? ›

P/E ratio as of July 2024 (TTM): -3.16

According to Senseonics Holdings 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.16481. At the end of 2022 the company had a P/E ratio of 3.43.

What guns does Sens have? ›

  • Primary Weapon. POF9. ASSAULT RIFLE. 417. Marksman Rifle.
  • Secondary Weapon. SDP 9mm. HANDGUN. Gonne-6. Hand Cannon.
  • Gadget. Claymore. HARD BREACH CHARGE.
  • Unique Ability. R.O.U. Projector System.

Is Senseonics a good investment? ›

Overall, Senseonics Holdings Inc stock has a Value Grade of F, Growth Grade of C, Momentum Grade of D .

Is NextEra a buy sell hold? ›

Is NextEra Energy stock a Buy, Sell or Hold? NextEra Energy stock has received a consensus rating of buy. The average rating score is and is based on 60 buy ratings, 11 hold ratings, and 1 sell ratings.

References

Top Articles
Latest Posts
Article information

Author: Roderick King

Last Updated:

Views: 6632

Rating: 4 / 5 (71 voted)

Reviews: 86% of readers found this page helpful

Author information

Name: Roderick King

Birthday: 1997-10-09

Address: 3782 Madge Knoll, East Dudley, MA 63913

Phone: +2521695290067

Job: Customer Sales Coordinator

Hobby: Gunsmithing, Embroidery, Parkour, Kitesurfing, Rock climbing, Sand art, Beekeeping

Introduction: My name is Roderick King, I am a cute, splendid, excited, perfect, gentle, funny, vivacious person who loves writing and wants to share my knowledge and understanding with you.